Salutemlab Formulations Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 06-12-2024
- Paid Up Capital ₹ 0.10 M
as on 06-12-2024
- Company Age 1 Year 2 Months
About Salutemlab Formulations
The Company is engaged in the Paper Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sahil Mahajan and Naresh Mahajan serve as directors at the Company.
- CIN/LLPIN
U21002JK2023PTC015130
- Company No.
015130
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Oct 2023
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Jammu
Industry
Company Details
- Location
Jammu, Jammu & Kashmir, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Salutemlab Formulations?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sahil Mahajan  | Director | 05-Oct-2023 | Current |
| Naresh Mahajan | Director | 05-Oct-2023 | Current |
Financial Performance and Corporate Structure Insights of Salutemlab Formulations.
Enhance accessibility to Salutemlab Formulations's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Salutemlab Formulations?
Unlock access to Salutemlab Formulations's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Ravenbhel Pharmaceuticals Private LimitedActive 24 years 8 daysSahil Mahajan and Naresh Mahajan are mutual person
Macmillon Pharmaceuticals Private LimitedActive 36 years 3 monthsSahil Mahajan and Naresh Mahajan are mutual person
Ravenmac Pharmaceuticals Private LimitedActive 14 years 9 monthsSahil Mahajan and Naresh Mahajan are mutual person
Salutemlife Sciences Private LimitedActive 1 year 2 monthsSahil Mahajan and Naresh Mahajan are mutual person
- Polycoatt Films Private LimitedActive 11 months 18 days
Sahil Mahajan and Naresh Mahajan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Salutemlab Formulations?
Unlock and access historical data on people associated with Salutemlab Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Salutemlab Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Salutemlab Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
